Concepedia

Ranjan Upadhyay

RU

Statistics

Publications

7

Citations

831

H-Index

7

Active since

2011

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Tisch Hospital

Celldex Therapeutics (United States)

Ranjan Upadhyay is an author at Icahn School of Medicine at Mount Sinai specializing in cancer immunotherapy, cancer immunology, and oncology.

ORCID

Publications per year

2011–2025

7

Publications

7

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

Linda Hammerich, Thomas U. Marron, Ranjan Upadhyay et al. · Nature Medicine · 2019 · 434 citations

, , +16

A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

Ranjan Upadhyay, Jonathan Boiarsky, Gvantsa Pantsulaia et al. · Cancer Discovery · 2021 · 209 citations · Full text

, , +17

Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity

Judit Svensson‐Arvelund, Sara Cuadrado‐Castano, Gvantsa Pantsulaia et al. · Nature Communications · 2022 · 71 citations · Full text

, , +17

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Hind Rafei, Rafet Başar, Sunil Acharya et al. · Nature · 2025 · 42 citations · Full text

, , +17

Uncovering the behaviors of individual cells within a multicellular microvascular community

Hesam Parsa, Ranjan Upadhyay, Samuel K. Sia · Proceedings of the National Academy of Sciences · 2011 · 33 citations · Full text

, , +11

1–5 of 7